Jack Henry & Associates Inc
F:JHY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jack Henry & Associates Inc
F:JHY
|
US |
|
A
|
ANI Pharmaceuticals Inc
SWB:BSFA
|
US |
|
Resaas Services Inc
XTSX:RSS
|
CA |
|
S
|
SFC Energy AG
LSE:0MVY
|
DE |
|
Boralex Inc
TSX:BLX
|
CA |
|
D
|
De Nora India Ltd
BSE:590031
|
IN |
|
P
|
PPL Corp
F:PP9
|
US |
|
Eupraxia Pharmaceuticals Inc
NASDAQ:EPRX
|
CA |
|
Edison International
NYSE:EIX
|
US |
Wall St Price Targets
JHY Price Targets Summary
Jack Henry & Associates Inc
According to Wall Street analysts, the average 1-year price target for JHY is 178.97 EUR with a low forecast of 150.5 EUR and a high forecast of 202.13 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is JHY's stock price target?
Price Target
178.97
EUR
According to Wall Street analysts, the average 1-year price target for JHY is 178.97 EUR with a low forecast of 150.5 EUR and a high forecast of 202.13 EUR.
What is the Revenue forecast for Jack Henry & Associates Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 7%.
What is the Operating Income forecast for Jack Henry & Associates Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 9%.
What is the Net Income forecast for Jack Henry & Associates Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 9%.
